SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sinclair, J. M.A.
Right arrow Articles by Latifi, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinclair, J. M.A.
Right arrow Articles by Latifi, A. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Co-morbid substance misuse in psychiatric patients: prevalence and association with length of inpatient stay

Julia M.A. Sinclair

Division of Clinical Neurosciences, Department of Mental Health, University of Southampton, Royal South Hants Hospital, Brintons Terrace, Southampton SO14 0YG, UK, julia.Sinclair{at}Soton.ac.uk

Abdul Hameed Latifi

OBMH Trust, Oxford, UK

Abdul Waheed Latifi

OBMH Trust, Oxford, UK

Improved management of mental illneSS with co-morbid SubStance miSuSe iS an important clinical objective. ThiS Study aimed to aSSeSS the prevalence of SubStance miSuSe in pSychiatric inpatientS, and to examine the relationShip between alcohol miSuSe and length of hoSpital admiSSion. A prevalence Study conducted over four monthS, examined rateS of co-morbid SubStance miSuSe in patientS admitted for pSychiatric inpatient care. Demographic detailS and length of hoSpital Stay were collected for all patientS and thoSe who gave informed conSent were Screened for levelS of alcohol and SubStance miSuSe. Two hundred and thirty-eight patientS were admitted during the Study period in which 178 (74.8%) conSented to take part in the Study. A group of 44 (50.6%) men and 26 (29.2%) women were Screened poSitive for alcohol miSuSe ({chi}2 = 8.7, P = 0.003). CannabiS uSe waS acknowledged by 31 (35.2%) men and 10 (11.2%) women ({chi}2 = 13.5, P < 0.0001). PreSence of co-morbid alcohol miSuSe waS aSSociated with a Significantly Shorter hoSpital admiSSion (z = 3.34, P = 0.0008). Co-morbid SubStance miSuSe (including alcohol) waS reported Significantly more frequently by men than women. Overall, patientS with co-morbid alcohol miSuSe had Shorter hoSpital admiSSionS, SuggeSting different patternS of preSentation and progreSS in hoSpital. HoSpital admiSSion preSentS an opportunity to identify SubStance miSuSe and evaluate treatmentS for co-morbid conditionS within a Safe environment.

Key Words: pSychiatric inpatientS • co-morbidity • SubStance uSe • alcohol uSe • prevalence

Journal of Psychopharmacology, Vol. 22, No. 1, 92-99 (2008)
DOI: 10.1177/0269881107082029
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement